PMS-SULFACETAMIDE SOD OPH SOLN 30% 300 MG
SULFACETAMIDE SODIUM : 300 MG · DIN 00762059 · PHARMASCIENCE INC
Health Canada status: CANCELLED POST MARKET
What is PMS-SULFACETAMIDE SOD OPH SOLN 30%?
PMS-SULFACETAMIDE SOD OPH SOLN 30% 300 MG contains SULFACETAMIDE SODIUM : 300 MG. It is listed in the Health Canada Drug Product Database under DIN 00762059, held by PHARMASCIENCE INC, supplied as DROPS for OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 28-Oct-2016. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00762059 |
|---|---|
| Brand name | PMS-SULFACETAMIDE SOD OPH SOLN 30% |
| Generic / active ingredient | SULFACETAMIDE SODIUM : 300 MG |
| Manufacturer | PHARMASCIENCE INC |
| Strength | 300 MG |
| Dosage form | DROPS |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01AB04 SULFACETAMIDE |
| AHFS class | 52:04.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 28-Oct-2016 |
| Original market date | 1991-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code S01AB04 SULFACETAMIDE. 0 of 13 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BALSULPH OPH LIQ 10.0% | 100 MG | DROPS | BAUSCH & LOMB CANADA INC. | CANCELLED POST MARKET | DIN 00772313 |
| BALSULPH OPH ONT 10.0% | 10 % | OINTMENT | BAUSCH & LOMB CANADA INC. | CANCELLED POST MARKET | DIN 00790842 |
| BLEPH 10 DPS | 10 % | DROPS | ALLERGAN INC | CANCELLED POST MARKET | DIN 00001287 |
| CETAMIDE ONT 10% | 10 % | OINTMENT | ALCON CANADA INC | CANCELLED POST MARKET | DIN 00252522 |
| ODAN-SULFACETAMIDE | 10 % | SOLUTION | ODAN LABORATORIES LTD | DORMANT | DIN 00622966 |
| OPHTHO-SULF LIQ 10% | 10 % | LIQUID | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 00707465 |
| PMS-SULFACETAMIDE SODIUM LIQ 10% | 10 % | LIQUID | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 00838934 |
| SODIUM SULAMYD 10% | 100 MG | DROPS | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 00028053 |
| SODIUM SULAMYD OPH DPS 30% | 300 MG | DROPS | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | DIN 00028061 |
| SODIUM SULAMYD OPH ONT 10% | 10 % | OINTMENT | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | DIN 00028347 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.